Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys.
other
Where this comes from
- Record sourced from PubMed, PMID 7752001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To differentiate gonadotropin deficiency from delayed puberty in teenage boys, 0.1 mg/m2 of triptorelin, a gonadotropin-releasing hormone agonist, was administered subcutaneously at 4 AM. Serum gonadotropins and testosterone levels were determined at baseline and 4 hours after the injection. The increase in blood gonadotropin and testosterone levels was significantly greater in patients with delayed puberty than in those with gonadotropin deficiency.
Medical subject headings
- Hypogonadism
- Puberty, Delayed
- Triptorelin Pamoate